Cargando…

Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies

BACKGROUND: The antiphospholipid syndrome (APS) is defined by simultaneous presence of vascular clinical events and antiphospholipid antibodies (aPL). The aPL considered as diagnostics are lupus anticoagulant and antibodies anticardiolipin (aCL) and anti-ß2 glycoprotein-I (aB2GP1). During recent yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tortosa, Carlos, Cabrera-Marante, Oscar, Serrano, Manuel, Martínez-Flores, José A., Pérez, Dolores, Lora, David, Morillas, Luis, Paz-Artal, Estela, Morales, José M., Pleguezuelo, Daniel, Serrano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519006/ https://www.ncbi.nlm.nih.gov/pubmed/28727732 http://dx.doi.org/10.1371/journal.pone.0178889

Ejemplares similares

The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events
por: Martínez-Flores, José A., et al.
Publicado: (2016)

Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease
por: Serrano, Manuel, et al.
Publicado: (2014)

Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation
por: Serrano, Manuel, et al.
Publicado: (2019)

Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
por: Ruiz-García, Raquel, et al.
Publicado: (2014)

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
por: Garcinuño, Sara, et al.
Publicado: (2022)

Perforin gene variant A91V in young patients with severe COVID-19
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2021)

An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2022)

The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped)
por: Serrano, Manuel, et al.
Publicado: (2019)

Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
por: Naranjo, Laura, et al.
Publicado: (2021)

Pretransplant IgA-Anti-Beta 2 Glycoprotein I Antibodies As a Predictor of Early Graft Thrombosis after Renal Transplantation in the Clinical Practice: A Multicenter and Prospective Study
por: Morales, Jose M., et al.
Publicado: (2018)

Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
por: Sweiss, Nadera J., et al.
Publicado: (2010)

Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management
por: López-Nevado, Marta, et al.
Publicado: (2021)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Exosomes as Carriers of Alzheimer's Amyloid-ß
por: Yuyama, Kohei, et al.
Publicado: (2017)

Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery
por: Utrero-Rico, Alberto, et al.
Publicado: (2021)

Galectin-8 in IgA Nephritis: Decreased Binding of IgA by Galectin-8 Affinity Chromatography and Associated Increased Binding in Non-IgA Serum Glycoproteins
por: Carlsson, Michael C., et al.
Publicado: (2011)

Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome
por: Pérez, Dolores, et al.
Publicado: (2018)

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
por: Naranjo, Laura, et al.
Publicado: (2022)

Flow cytometry detection of sustained humoral immune response (IgG + IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection
por: Piñero, Paula, et al.
Publicado: (2021)

IL-6–based mortality risk model for hospitalized patients with COVID-19
por: Laguna-Goya, Rocio, et al.
Publicado: (2020)

IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus
por: Siddiqui, Saima, et al.
Publicado: (2020)

IgA is the predominant isotype of anti‐β2 glycoprotein I antibodies in rheumatoid arthritis
por: Melayah, Sarra, et al.
Publicado: (2020)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Fatal pulmonary thromboembolism in asymptomatic COVID-19
por: Keane, Gerard, et al.
Publicado: (2021)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Two Cases of Multiple Thromboembolism With Asymptomatic Atrial Fibrillation
por: Tanaka, Yudai, et al.
Publicado: (2022)

Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β(2) glycoprotein I domain 1 antibodies
por: Elbagir, S, et al.
Publicado: (2020)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

Cholecystokinin Outcome on Markers of Intestinal IgA Antibody Response
por: Morales-Magaña, Juan, et al.
Publicado: (2022)

Outcomes of nicotinic modulation on markers of intestinal IgA antibody response
por: Carrizales-Luna, Jorge Emmanuel, et al.
Publicado: (2022)

Frequency of serological markers of rheumatoid arthritis in patients with IgA anti‐β2 glycoprotein I antibodies
por: Melayah, Sarra, et al.
Publicado: (2022)

An Epidemiological Model of Malaria Accounting for Asymptomatic Carriers
por: Aguilar, Jacob B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_38pbr8e0e3hbhdm9r93gr11v6o